• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Pharmacovigilance Analytics

Your best resource for PV analytics news, content and innovation!

  • Home
  • Pharmacovigilance Analytics
    • Sources of data
    • Methods and tools
  • Signal Detection and Management in Pharmacovigilance
  • News
  • Opinion
  • About
  • Glossary

Methods and tools

Methods and tools used in drug safety analytics and pharmacovigilance analytics

Following are the techniques / tools we use in the fields of data mining, text and information mining, geographic information systems, and visualization analytics.

Data mining

Among the several statistical techniques covered in data mining, PV analytics will use the following:

  • Descriptive modeling, used to uncover shared similarities or groupings in historical data to determine reasons behind success or failure. Descriptive analytics tell us what happened, and why, and also what’s happening right now and why. Techniques belonging to this group are, among others:
    • clustering
    • anomaly -outlier- detection
    • association rule learning
    • principal components analysis
    • affinity grouping
  • Predictive modeling, used to classify events in the future or estimate unknown outcomes. Predictive analytics will tell us what is likely to happen, and why. Techniques in this domain are:
    • regression
    • artificial neural networks
    • decision trees, random forest
    • support vector machines

We provide some examples of predictive models applied to drug safety and pharmacovigilance here.

  • Prescriptive modeling, which is also called “the last frontier of analytic capabilities”, takes information from descriptive and predictive analytics and combines it with information obtained from unstructured data (text mining, web mining) for improved prediction accuracy. Prescriptive modeling looks at internal and external variables and constraints, to recommend one or more courses of action. Predictive analytics + rules, and marketing optimization are examples of prescriptive modeling.
    Prescriptive analytics can tell us what our options are, and what we should do.
  • Disproportionality methods, specific to patient safety, are used to identify statistical associations between products and events. Such methods compare the observed count for a product-event combination with an expected count. The expected counts can be obtained from large public databases like FAERS for drug-event combinations, or the Manufacturer and User Facility Device Experience (MAUDE) for device-event combinations.
    The proportional reporting ratio (PRR) and the reporting odds ratio (ROR) are the foundational concepts for many disproprotionality methods. However,  when the number of observed or expected reports is small, more advanced methods are employed, such as the Multi-item Gamma Poisson Shrinker (MGPS), which produces Empirical Bayesian Geometric Mean (EBGM) scores.

Geographic Information Systems (GIS)

  • GIS can be used to identify geographic trends over time, perform surveillance, visualize the locations of patients and determine if there are clusters of specific types of customer or patient experiences. These systems allow for the use of different layers of information.
  • It also provides a method in which we can systematically address where certain events are more likely to occur and implement preventive or corrective measures. Tracking the spread of infectious diseases or preforming outbreak investigations are well known uses of GIS.
  • Another interesting layer of information will be incorporating social media: it can play a significant role, as in the case of tweets informing of healthcare-related issues in relation to patients on company medicinal products.
  • Tracking potential safety problems with GIS can provide new opportunities for real-time interventions, and identification of patients at risk, patterns, and areas where patient education and assistance may be adequate.
  • GIS allows us to visualize, question, analyze, interpret, and understand data to reveal relationships, patterns and trends, perform surveillance and documentation of the geographic components of the diseases targeted by the company and its risk factors, and can help with disease prevention programs and policies.

Text and information mining

  • An important part of the AE reporting is unstructured (narratives, event descriptions), as well as the information obtained from the Internet.
  • Text and information mining help to detect specific text patterns or combinations, as well as trends.

Visualization tools

  • Visualization analytics encompasses the use of pictures and graphics to facilitate the understanding of complex data relationships by displaying data in a visually meaningful way.
  • Very useful and fundamental instrument for visualizing patterns in the environment of multiple-source data integration. Widely used in healthcare data analytics.
Related Terms:
  • Term: Drug Safety
  • Term: Data Mining
  • Term: Bayesian
  • Term: Geographic Information Systems (GIS)

Primary Sidebar

Subscribe in a reader

Search Website

Uses of Generative AI in Pharmacovigilance

Featured News / Posts

Signal Analytics Technology in Pharmacovigilance

Signal Analytics Technology in Pharmacovigilance: Enhancing Drug Safety Monitoring

Pharmacovigilance plays a crucial role in ensuring public safety by monitoring, … [Read More...] about Signal Analytics Technology in Pharmacovigilance: Enhancing Drug Safety Monitoring

8 Common FDA Applications for Drugs & Biologics

The U.S. Food and Drug Administration (FDA) has several types of applications … [Read More...] about 8 Common FDA Applications for Drugs & Biologics

Key IND Enabling Studies: Navigating Preclinical Development Regulations

Investigational New Drug (IND) applications represent a critical stage in the … [Read More...] about Key IND Enabling Studies: Navigating Preclinical Development Regulations

Pharmacokinetics and Pharmacodynamics (PKPD): Fundamentals in Drug Development and Therapeutic Effectiveness

Pharmacokinetics and pharmacodynamics are two fundamental pillars in the field … [Read More...] about Pharmacokinetics and Pharmacodynamics (PKPD): Fundamentals in Drug Development and Therapeutic Effectiveness

Current Regulations Regarding Reference Safety Information (RSI): Key Aspects and Updates

Regulatory authorities in the pharmaceutical industry have established standards … [Read More...] about Current Regulations Regarding Reference Safety Information (RSI): Key Aspects and Updates

Methods of Statistical Signal Detection in Patient Safety and Pharmacovigilance: Key Techniques and Approaches

In the realm of patient safety and pharmacovigilance, statistical signal … [Read More...] about Methods of Statistical Signal Detection in Patient Safety and Pharmacovigilance: Key Techniques and Approaches

Pharmacovigilance Signal Detection Software: Enhancing Drug Safety and Monitoring

Pharmacovigilance signal detection software plays a crucial role in … [Read More...] about Pharmacovigilance Signal Detection Software: Enhancing Drug Safety and Monitoring

What is a PBRER? Understanding Periodic Benefit-Risk Evaluation Reports

A Periodic Benefit-Risk Evaluation Report (PBRER) serves as a structured … [Read More...] about What is a PBRER? Understanding Periodic Benefit-Risk Evaluation Reports

Drug Safety vs Pharmacovigilance: Exploring Conceptual Differences

Drug safety and pharmacovigilance are crucial aspects of public … [Read More...] about Drug Safety vs Pharmacovigilance: Exploring Conceptual Differences

Which Sections of a DSUR Must Present Safety and Pharmacovigilance Quantitative Data: Key Components Explained

he Development Safety Update Report (DSUR) is a crucial document that serves as … [Read More...] about Which Sections of a DSUR Must Present Safety and Pharmacovigilance Quantitative Data: Key Components Explained

  • What is a DSUR (Development Safety Update Report)? An Essential Guide for Clinical Research
  • What is a BLA (Biologics License Application)? Essential Guide for Professionals
  • What is a PADER? – Periodic Adverse Drug Experience Report Explained

RSS ICH News

  • An error has occurred, which probably means the feed is down. Try again later.

RSS From Nature journal

  • Gene Therapy with Enterovirus 3 C Protease: A Promising Strategy for Various Solid Tumors
  • Exploratory analysis of long-term suppressive therapy with dalbavancin in ventricular assist device infections caused by Staphylococcus aureus
  • Designing and characterizing first Iranian study evaluating serum levels of lithium in patients for population pharmacokinetics (FIRELOLIPOP): baseline and first report
  • Application of new approach methodologies for nonclinical safety assessment of drug candidates
  • FAERS based disproportionality analysis and network pharmacology investigation of taxanes associated drug induced liver injury

Copyright © 2025 · News Pro on Genesis Framework · WordPress · Log in